Data sleuths have flagged apparent errors in the study, which was led by neuroscientist Thomas Südhof.

Nearly two-thirds of the article’s references appear to not exist.

The collection offers a glimpse into differences in cell composition — across people and brain regions — that may shape neural function.

A combination of automation and social curation can help keep early-career researchers from drowning in the sea of scientific publications.

Alterations in inhibitory circuits and difficulties in social recognition characterize mice missing one copy of DYRK1A, a gene linked to autism.

After 10 years of work, Neurona may have the data to quiet its skeptics. But its ongoing clinical trial will be the ultimate test.

Going forward, the American College of Neuropsychopharmacology plans to gather at “non-discriminatory sites,” following the passage of Florida laws targeting LGBTQ+ people and reproductive rights.

The mutations disrupt protein translation as well as the cell’s skeleton, according to a new study.

Increasing or reducing the levels of the UBE3A gene, which is associated with autism and autism-related syndromes, results in altered patterns of synaptic pruning — a process that snips away brain cell connections.

This month’s Going on Trial newsletter explores how eye tracking might be used beyond helping with diagnosis, among other drug development news.